N@N

Graig Suvannavejh Maintained (APLS) at Hold with Decreased Target to $52 on, Apr 29th, 2024

Graig Suvannavejh of Mizuho, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Hold with Decreased Target from $60 to $52 on, Apr 29th, 2024.

Graig has made no other calls on APLS in the last 4 months.

There are 10 other peers that have a rating on APLS. Out of the 10 peers that are also analyzing APLS, 1 agrees with Graig's Rating of Hold. Following is the relevant analyst calls for the last 4 months

---

• Laura Chico of "Wedbush" Maintained at Hold with Decreased Target to $57 on, Wednesday, April 17th, 2024

These are the ratings of the 9 analyists that currently disagree with Graig

---

• Douglas Tsao of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $92 on, Friday, April 26th, 2024
• Joseph Stringer of "Needham" Reiterated at Strong Buy and Held Target at $85 on, Thursday, April 25th, 2024
• Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $79 on, Wednesday, March 6th, 2024
• Eliana Merle of "UBS" Maintained at Strong Buy with Increased Target to $89 on, Monday, March 4th, 2024
• Colleen Kusy of "Baird" Reiterated at Buy and Held Target at $81 on, Tuesday, February 6th, 2024
• Akash Tewari of "Jefferies" Upgraded from Hold to Strong Buy and Increased Target to $80 on, Monday, February 5th, 2024
• Justin Kim of "Oppenheimer" Maintained at Buy with Increased Target to $79 on, Tuesday, January 30th, 2024
• Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Increased Target to $106 on, Thursday, January 11th, 2024
• Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $90 on, Tuesday, January 9th, 2024

Contributing Sources

---